| Names | |
|---|---|
| Preferred IUPAC name N-(Acetylcarbamoyl)-2-bromo-2-ethylbutanamide | |
| Other names 1-Acetyl-3-(2-bromo-2-ethylbutyryl)urea | |
| Identifiers | |
3D model (JSmol) | |
| ChEMBL | |
| ChemSpider | |
| ECHA InfoCard | 100.000.953 |
| EC Number |
|
| KEGG | |
| MeSH | acecarbromal |
PubChem CID | |
| UNII | |
CompTox Dashboard (EPA) | |
| |
| |
| Properties | |
| C9H15BrN2O3 | |
| Molar mass | 279.134 g·mol−1 |
| Pharmacology | |
| Oral | |
| Legal status |
|
| Related compounds | |
Related compounds | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Acecarbromal (INN) (brand names Sedamyl, Abasin, Carbased, Paxarel, Sedacetyl, numerous others), also known as acetylcarbromal and acetyladalin, is a hypnotic and sedative drug of the ureide (acylurea) group discovered by Bayer in 1917 [1] that was formerly marketed in the United States and Europe. [2] [3] It is also used in combination with extract of quebracho and vitamin E as a treatment for erectile dysfunction under the brand name Afrodor in Europe. [4] [5] [6] Acecarbromal is structurally related to the barbiturates, which are basically cyclized ureas. [7] Prolonged use is not recommended as it can cause bromine poisoning. [7]